PPARγ population shift produces disease-related changes in molecular networks associated with metabolic syndrome

Cell Death and Disease

Volumn 2, Issue 8, 2011, Pages

  Jurkowski, W ^a   Roomp, K ^a   Crespo, I ^a   Schneider, J G ^a   Del Sol, A ^a  

^a UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

Bi stable switches; Disease related networks; Metabolic syndrome; PPARg; Protein population shift

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; GENE EXPRESSION; HUMAN; METABOLIC SYNDROME X; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; STRUCTURE ANALYSIS; CHEMISTRY; DIMERIZATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE;

DIMERIZATION; GENE EXPRESSION REGULATION; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METABOLIC SYNDROME X; PHOSPHORYLATION; PPAR GAMMA; PROTEIN STRUCTURE, TERTIARY; RETINOID X RECEPTOR ALPHA;

EID: 80052323083     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.74     Document Type: Article

References (40)

1. Huang S, Ernberg I, Kauffman S. Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin Cell Dev Biol 2009; 20: 869-876.
2. Boehr DD, Nussinov R, Wright PE. The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol 2009; 5: 789-796.
3. Mohan A, Uversky VN, Radivojac P. Influence of sequence changes and environment on intrinsically disordered proteins. PLoS Comput Biol 2009; 5: e1000497.
4. Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982; 218: 1309-1311.
5. Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E. Cell-to-cell transmission of nonprion protein aggregates. Nat Rev Neurol 2010; 6: 702-706.
6. Brundin P, Melki R, Kopito R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 2010; 11: 301-307.
7. Wilmarth PA, Tanner S, Dasari S, Nagalla SR, Riviere MA, Bafna V et al. Age-related changes in human crystallins determined from comparative analysis of post-translational modifications in young and aged lens: does deamidation contribute to crystallin insolubility? J Proteome Res 2006; 5: 2554-2566. (Pubitemid 44595158)
8. Fritz G, Botelho HM, Morozova-Roche LA, Gomes CM. Natural and amyloid self-assembly of S100 proteins: structural basis of functional diversity. FEBS J 2010; 277: 4578-4590.
9. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetes Med 2006; 23: 469-480.
10. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359. (Pubitemid 34251969)
11. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834. (Pubitemid 41094278)
12. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374. (Pubitemid 38702847)
13. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27: 2676-2681. (Pubitemid 39441469)
14. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250. (Pubitemid 39202340)
15. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428. (Pubitemid 40523737)
16. Lehrke M, Lazar MA. The many faces of PPARgamma. Cell 2005; 123: 993-999.
17. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995; 270: 12953-12956.
18. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl JMed 1998; 339: 953-959. (Pubitemid 28455097)
19. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287. (Pubitemid 28507675)
20. Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, Laznik D et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 2010; 466: 451-456.
21. Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP et al. Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature 2008; 456: 350-356.
22. Alon U. An Introduction to Systems Biology: Design Principles of Biological Circuits. Chapman and Hall/CRC: Boca Raton, FL, USA, 2006.
23. Yun Z, Maecker HL, Johnson RS, Giaccia AJ. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2002; 2: 331-341. (Pubitemid 34266118)
24. Boyle KB, Hadaschik D, Virtue S, Cawthorn WP, Ridley SH, O'Rahilly S et al. The transcription factors Egr1 and Egr2 have opposing influences on adipocyte differentiation. Cell Death Differ 2009; 16: 782-789.
25. Tenney R, Stansfield K, Pekala PH. Interleukin 11 signaling in 3T3-L1 adipocytes. J Cell Physiol 2005; 202: 160-166. (Pubitemid 39603373)
26. Kennedy RL, Thomas L, Garland S, Kazi M. CXCL12 (stromal cell derived factor-1) secretion by preadipocytes is enhanced by short-chain fatty acids acting through a G protein-coupled receptor (GPR41). ESA Annual Scientific Meeting 2007, 2-5 September 2007, Christchurch, New Zealand, 2007.
27. Wang CC, Goalstone ML, Draznin B. Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes 2004; 53: 2735-2740. (Pubitemid 39425897)
28. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1995; 15: 351-357. (Pubitemid 24379933)
29. Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia 1999; 42: 1033-1049.
30. Singh S, Loke YK, Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 2007; 298: 1189-1195. (Pubitemid 47403105)
31. Schoonjans K, Auwerx J. Thiazolidinediones: an update. Lancet 2000; 355: 1008-1010. (Pubitemid 30148273)
32. Menghini R, Marchetti V, Cardellini M, Hribal ML, Mauriello A, Lauro D et al. Phosphorylation of GATA2 by Akt increases adipose tissue differentiation and reduces adipose tissue-related inflammation: a novel pathway linking obesity to atherosclerosis. Circulation 2005; 111: 1946-1953. (Pubitemid 40570214)
33. Menghini R, Menini S, Amoruso R, Fiorentino L, Casagrande V, Marzano V et al. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 2009; 136: 663-672 e664.
34. Cardellini M, Menghini R, Martelli E, Casagrande V, Marino A, Rizza S et al. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 2009; 58: 2396-2401.
35. Bernot D, Barruet E, Poggi M, Bonardo B, Alessi MC, Peiretti F. Down-regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) expression is necessary for adipocyte differentiation. J Biol Chem 2010; 285: 6508-6514.
36. Rangwala SM, Rhoades B, Shapiro JS, Rich AS, Kim JK, Shulman GI et al. Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev Cell 2003; 5: 657-663. (Pubitemid 37243053)
37. Chen L, Wang R, Zhang X. Biomolecular Networks: Methods and Applications in Systems Biology. John Wiley & Sons Inc.: Hoboken, New Jersey, 2009.
38. Hess B, Kutzner C, van der Spoel D, Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008; 4: 435-447.
39. Wernicke S, Rasche F. FANMOD: a tool for fast network motif detection. Bioinformatics 2006; 22: 1152-1153.
40. Di Cara A, Garg A, De Micheli G, Xenarios I, Mendoza L. Dynamic simulation of regulatory networks using SQUAD. BMC Bioinformatics 2007; 8: 462.